Isolation of a recombinant type 3/type 2 poliovirus with a chimeric capsid VP1 from sewage in Shandong, China

Virus Research

Volumn 150, Issue 1-2, 2010, Pages 56-60

  Tao, Zexin ^a   Wang, Haiyan ^a   Xu, Aiqiang ^a   Zhang, Yong ^b   Song, Lizhi ^a   Zhu, Shuangli ^b   Li, Yan ^a   Yan, Dongmei ^b   Liu, Guifang ^a   Yoshida, Hiromu ^c   Liu, Yao ^a   Feng, Lei ^a   Chosa, Toru ^d   Xu, Wenbo ^b  

^a SHANDONG CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Capsid; Evolution; Genome; Poliovirus; Recombinant

Indexed keywords

PROTEIN VP1;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHINA; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SEWAGE; VIRAL GENETICS; VIRUS GENOME; VIRUS ISOLATION; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANTIBODIES, VIRAL; CAPSID PROTEINS; CHINA; CLUSTER ANALYSIS; GENOTYPE; HOT TEMPERATURE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; POLIOVIRUS; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SEROTYPING; SEWAGE; VIRUS REPLICATION;

MIRIDAE; POLIOVIRUS;

EID: 77952238099     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.02.014     Document Type: Article

References (24)

1. Balanant J., Guillot S., Candrea A., Delpeyroux F., Crainic R. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 1991, 184:645-654.
2. Birmingham M.F., Linkins R.W., Hull B.P., Hull H.F. Poliomyelitis surveillance, the compass for eradication. J. Infect. Dis. 1997, 175:S146-S150.
3. Blomqvist S., Bruu A.L., Stenvik M., Hovi T. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccine and containing a chimeric capsid protein VP1. J. Gen. Virol. 2003, 84:573-580.
4. Blomqvist S., Savolainen C., Laine P., Hirttiö P., Lamminsalo E., Penttilä E., Jöks S., Roivainen M., Hovi T. Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia. J. Virol. 2004, 78:4876-4883.
5. Chumakov K.M., Norwood L.P., Parker M.L., Dragunsky E.M., Ran Y., Levenbook I.S. RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence. J. Virol. 1992, 66:966-970.
6. Cuervo N.S., Guillot S., Romanenkova N., Combiescu M., Aubert-Combiescu A., Seghier M., Caro V., Crainic R., Delpeyroux F. Genomic features of intertypic recombinant Sabin poliovirus strains excreted by primary vaccinees. J. Virol. 2001, 75:5740-5751.
7. Dedepsidis E., Pliaka V., Kyriakopoulou Z., Brakoulias C., Levidiotou-Stefanou S., Pratti A., Mamuris Z., Markoulatos P. Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant. FEMS Immunol. Med. Microbiol. 2008, 52:343-351.
8. El Bassioni L., Barakat I., Nasr E., de Gourville E.M., Hovi T., Blomqvist S., Burns C., Stenvik M., Gary H., Kew O.M., Pallansch M.A., Wahdan M.H. Prolonged detection of indigenous wild polioviruses in sewage from communities in Egypt. Am. J. Epidemiol. 2003, 158:807-815.
9. Furione M., Guillot S., Otelea D., Balanant J., Candrea A., Crainic R. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 1993, 196:199-208.
10. Guillot S., Caro V., Cuervo N., Korotkova E., Combiescu M., Persu A., Aubert-Combiescu A., Delpeyroux F., Crainic R. Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J. Virol. 2000, 74:8434-8443.
11. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 1999, 41:95-98.
12. Iwai M., Yoshida H., Matsuura K., Fujimoto T., Shimizu H., Takizawa T., Nagai Y. Molecular epidemiology of echoviruses 11 and 13, based on an environmental surveillance conducted in Toyama Prefecture, 2002-2003. Appl. Environ. Microbiol. 2006, 72:6381-6387.
13. Jorba J., Campagnoli R., De L., Kew O. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J. Virol. 2008, 82:4429-4440.
14. Kew O.M., Sutter R.W., Nottay B.K., McDonough M.J., Prevots D.R., Quick L., Pallansch M.A. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J. Clin. Microbiol. 1998, 36:2893-2899.
15. Martin J., Dunn G., Hull R., Patel V., Minor P.D. Evolution of the sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J. Virol. 2000, 74:3001-3010.
16. Martin J., Samoilovich E., Dunn G., Lackenby A., Feldman E., Heath A., Svirchevskaya E., Cooper G., Yermalovich M., Minor P.D. Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J. Virol. 2002, 76:10921-10928.
17. Minor Y., Handsher R., Halmut T., Neuman M., Bobrov A., Rudich H., Vonsover A., Shulman L., Kew O., Mendelson E. Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. J. Clin. Microbiol. 1999, 37:1670-1675.
18. Mueller J.E., Bessaud M., Huang Q.S., Martinez L.C., Barril P.A., Morel V., Balanant J., Bocacao J., Hewitt J., Gessner B.D., Delpeyroux F., Nates S.V. Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba province, Argentina. Appl. Environ. Microbiol. 2009, 75:1395-1401.
19. Rezapkin G.V., Norwood L.P., Taffs R.E., Dragunsky E.M., Levenbook I.S., Chumakov K.M. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control. Virology 1995, 211:377-384.
20. Shulman L.M., Manor Y., Handsher R., Delpeyroux F., McDonough M.J., Halmut T., Silberstein I., Alfandari J., Quay J., Fisher T., Robinov J., Kew O.M., Crainic R., Mendelson E. Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J. Clin. Microbiol. 2000, 38:3729-3734.
21. Stanway G., Brown F., Christian P., Hovi T., Hyypiä T., King A.M.Q., Knowles N.J., Lemon S.M., Minor P.D., Pallansch M.A., Palmenberg A.C., Skern T. Family Picornaviridae. Virus Taxonomy. Eighth Report of the International Committee on Taxonomy of Viruses 2005, 757-778. Elsevier/Academic Press, London. C.M. Fauquet, M.A. Mayo, J. Maniloff, U. Desselberger, L.A. Ball (Eds.).
22. WHO, 2004. Polio Laboratory Manual, fourth ed., Geneva, Switzerland.
23. Yoshida H., Horie H., Matsuura K., Kitamura T., Hashizume S., Miyamura T. Prevalence of vaccine-derived polioviruses in environment. J. Gen. Virol. 2002, 83:1107-1111.
24. Zhang Y., Wang H., Zhu S., Li Y., Song L., Liu Y., Liu G., Nishimura Y., Chen L., Yan D., Wang D., An H., Shimizu H., Xu A., Xu W. Characterization of a rare natural intertypic type 2/type 3 capsid penta-recombinant vaccine-derived Poliovirus isolated from a child with acute flaccid paralysis. J. Gen. Virol. 2009, 91:421-429.